ALGS
Aligos Therapeutics Inc
$0.8
Earnings Summary
Revenue | $2.68Mn |
Net Profits | $-27.89Mn |
Net Profit Margins | -1040.36% |
Highlights
Aligos Therapeutics Inc’s revenue fell -24.2% since last year same period to $2.68Mn in the Q4 2023. On a quarterly growth basis, Aligos Therapeutics Inc has generated -17.23% fall in its revenue since last 3-months.
Aligos Therapeutics Inc’s net profit fell -27.44% since last year same period to $-27.89Mn in the Q4 2023. On a quarterly growth basis, Aligos Therapeutics Inc has generated -54.6% fall in its net profits since last 3-months.
Aligos Therapeutics Inc’s net profit margin fell -68.13% since last year same period to -1040.36% in the Q4 2023. On a quarterly growth basis, Aligos Therapeutics Inc has generated -86.78% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Aligos Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Current Year | -0.19 |
Highlights
Aligos Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.19 - a 29.63% jump from last quarter’s estimates.
Aligos Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.19.
Key Ratios
Key ratios of the Aligos Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.22 |
Highlights
Aligos Therapeutics Inc’s earning per share (EPS) jumped 56.86% since last year same period to -0.22 in the Q4 2023. This indicates that the Aligos Therapeutics Inc has generated 56.86% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-04 | -0.48 | -0.53 | -10.42% |
2023-11-02 | -0.47 | -0.41 | 12.77% |
2024-03-12 | -0.27 | -0.22 | 18.52% |
2023-08-03 | -0.49 | -0.43 | 12.24% |
₹0 US Stocks a/c Opening Fee